Nexus AG is a software solution provider. The company functions through the Healthcare software and Healthcare service segments, which are responsible for providing information systems for hospitals, psychiatric, rehabilitation, and social institutions, and IT services for IT operations especially in healthcare systems. The company derives a majority of its revenues from the Healthcare software segment. Its geographical segments are Germany, Switzerland/Lichtenstein, Netherlands, Poland, France, Austria, and other regions.
1989
1.8K+
LTM Revenue $281M
LTM EBITDA n/a
$1.2B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Nexus has a last 12-month revenue of $281M and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Nexus achieved revenue of $281M and an EBITDA of $66.0M.
Nexus expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Nexus valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $259M | $281M | XXX | XXX | XXX |
Gross Profit | $190M | $218M | XXX | XXX | XXX |
Gross Margin | 73% | 78% | XXX | XXX | XXX |
EBITDA | $57.4M | $66.0M | XXX | XXX | XXX |
EBITDA Margin | 22% | 23% | XXX | XXX | XXX |
Net Profit | $20.8M | $25.8M | XXX | XXX | XXX |
Net Margin | 8% | 9% | XXX | XXX | XXX |
Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Nexus's stock price is EUR 70 (or $75).
Nexus has current market cap of EUR 1.2B (or $1.3B), and EV of EUR 1.1B (or $1.2B).
See Nexus trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$1.2B | $1.3B | XXX | XXX | XXX | XXX | $1.92 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Nexus has market cap of $1.3B and EV of $1.2B.
Nexus's trades at 4.2x LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Nexus's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Nexus and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $1.2B | XXX | XXX | XXX |
EV/Revenue | 4.2x | XXX | XXX | XXX |
EV/EBITDA | 18.0x | XXX | XXX | XXX |
P/E | 39.1x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | 26.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpNexus's NTM/LTM revenue growth is -100%
Nexus's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Nexus's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Nexus's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Nexus and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 8% | XXX | XXX | XXX | XXX |
EBITDA Margin | 23% | XXX | XXX | XXX | XXX |
EBITDA Growth | 15% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 4% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 71% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
Alcidion Group | XXX | XXX | XXX | XXX | XXX | XXX |
CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Nexus acquired XXX companies to date.
Last acquisition by Nexus was XXXXXXXX, XXXXX XXXXX XXXXXX . Nexus acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Nexus founded? | Nexus was founded in 1989. |
Where is Nexus headquartered? | Nexus is headquartered in Germany. |
How many employees does Nexus have? | As of today, Nexus has 1.8K+ employees. |
Is Nexus publicy listed? | Yes, Nexus is a public company listed on ETR. |
What is the stock symbol of Nexus? | Nexus trades under NXU ticker. |
When did Nexus go public? | Nexus went public in 2000. |
Who are competitors of Nexus? | Similar companies to Nexus include e.g. Benevolent AI, Alcidion Group, CurveBeam AI, Doctor Care Anywhere. |
What is the current market cap of Nexus? | Nexus's current market cap is $1.3B |
What is the current revenue of Nexus? | Nexus's last 12-month revenue is $281M. |
What is the current EV/Revenue multiple of Nexus? | Current revenue multiple of Nexus is 4.2x. |
What is the current revenue growth of Nexus? | Nexus revenue growth between 2023 and 2024 was 8%. |
Is Nexus profitable? | Yes, Nexus is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.